Items where Author is "Ganjalikhany, M. R."

(2024) An in silico investigation on the binding site preference of PD-1 and PD-L1 for designing antibodies for targeted cancer therapy. Plos One. p. 28. ISSN 1932-6203

(2023) Different aspects in explaining how mutations could affect the binding mechanism of receptor binding domain of SARS-CoV-2 spike protein in interaction with ACE2. Plos One. p. 17. ISSN 1932-6203

(2023) Knocking down the expression of the molecular motors, myosin A, C and F genes in <i>Toxoplasma gondii</i> to decrease the parasite virulence. Experimental Parasitology. p. 8. ISSN 0014-4894

(2021) Designing and generating a single-chain fragment variable (scFv) antibody against IL2R alpha (CD25): An in silico and in vitro study. Iranian Journal of Basic Medical Sciences. pp. 360-368. ISSN 2008-3866

(2021) In silico investigation of critical binding pattern in SARS-CoV-2 spike protein with angiotensin-converting enzyme 2. Scientific Reports. ISSN 2045-2322

(2021) A Novel CAR Expressing NK Cell Targeting CD25 With the Prospect of Overcoming Immune Escape Mechanism in Cancers. Frontiers in Oncology. ISSN 2234-943X

(2021) mRNA-Based Cancer Vaccines: A Therapeutic Strategy for the Treatment of Melanoma Patients. VACCINES. ISSN 2076-393X J9 - VACCINES-BASEL

(2020) Investigation of Supercharging as A Strategy to Enhance the Solubility and Plasminogen Cleavage Activity of Reteplase. Iranian Journal of Biotechnology. pp. 124-131. ISSN 1728-3043

(2020) Rational design of a new mutant of tobacco etch virus protease in order to increase the in vitro solubility. Research in Pharmaceutical Sciences. pp. 164-173. ISSN 1735-5362

(2019) Improving the solubility, activity, and stability of reteplase using in silico design of new variants. Research in Pharmaceutical Sciences. pp. 359-368. ISSN 1735-5362